Circular RNA AKT3 upregulates PIK3R1 to enhance cisplatin resistance in gastric cancer via miR-198 suppression
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Circular RNA AKT3 upregulates PIK3R1 to enhance cisplatin resistance in gastric cancer via miR-198 suppression
Authors
Keywords
Cisplatin resistance, Gastric cancer, circAKT3, Circular RNA, miR-198, PIK3R1
Journal
Molecular Cancer
Volume 18, Issue 1, Pages -
Publisher
Springer Nature
Online
2019-03-30
DOI
10.1186/s12943-019-0969-3
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The efficacy and safety of targeted therapy with or without chemotherapy in advanced gastric cancer treatment: a network meta-analysis of well-designed randomized controlled trials
- (2018) Ting-Ting Zhao et al. Gastric Cancer
- Tamoxifen-resistant breast cancer cells are resistant to DNA-damaging chemotherapy because of upregulated BARD1 and BRCA1
- (2018) Yinghua Zhu et al. Nature Communications
- Circular RNA circMTO1 acts as the sponge of microRNA-9 to suppress hepatocellular carcinoma progression
- (2017) Dan Han et al. HEPATOLOGY
- Human Helicase RECQL4 Drives Cisplatin Resistance in Gastric Cancer by Activating an AKT-YB1-MDR1 Signaling Pathway
- (2016) D. Mo et al. CANCER RESEARCH
- A circular RNA protects the heart from pathological hypertrophy and heart failure by targeting miR-223
- (2016) Kun Wang et al. EUROPEAN HEART JOURNAL
- Circular RNAs are miRNA sponges and can be used as a new class of biomarker
- (2016) Franceli Rodrigues Kulcheski et al. JOURNAL OF BIOTECHNOLOGY
- Genetic Determinants of Cisplatin Resistance in Patients With Advanced Germ Cell Tumors
- (2016) Aditya Bagrodia et al. JOURNAL OF CLINICAL ONCOLOGY
- Targeting therapeutic liabilities engendered by PIK3R1 mutations for cancer treatment
- (2016) Lydia WT Cheung et al. PHARMACOGENOMICS
- Circular RNA profiling reveals an abundant circHIPK3 that regulates cell growth by sponging multiple miRNAs
- (2016) Qiupeng Zheng et al. Nature Communications
- MIR517Cinhibits autophagy and the epithelial-to-mesenchymal (-like) transition phenotype in human glioblastoma through KPNA2-dependent disruption of TP53 nuclear translocation
- (2015) Yuntao Lu et al. Autophagy
- Global cancer statistics, 2012
- (2015) Lindsey A. Torre et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Update on Metastatic Gastric and Esophageal Cancers
- (2015) Manish A. Shah JOURNAL OF CLINICAL ONCOLOGY
- Genomically amplified Akt3 activates DNA repair pathway and promotes glioma progression
- (2015) Kristen M. Turner et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Mitochondrial fission determines cisplatin sensitivity in tongue squamous cell carcinoma through the BRCA1–miR-593-5p–MFF axis
- (2015) Song Fan et al. Oncotarget
- Epigenetic repression of phosphatidylethanolamine N-methyltransferase (PEMT) in BRCA1-mutated breast cancer
- (2015) Da Li et al. Oncotarget
- BRCA1 as a nicotinamide adenine dinucleotide (NAD)-dependent metabolic switch in ovarian cancer
- (2014) Da Li et al. CELL CYCLE
- Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012
- (2014) Jacques Ferlay et al. INTERNATIONAL JOURNAL OF CANCER
- Regulation of DNA methyltransferase 1 transcription in BRCA1-mutated breast cancer: a novel crosstalk between E2F1 motif hypermethylation and loss of histone H3 lysine 9 acetylation
- (2014) Da Li et al. Molecular Cancer
- BRCA1-IRIS inactivation sensitizes ovarian tumors to cisplatin
- (2014) B T Paul et al. ONCOGENE
- Systems biology of cisplatin resistance: past, present and future
- (2014) L Galluzzi et al. Cell Death & Disease
- SIRT1 and AMPK Mediate Hypoxia-Induced Resistance of Non-Small Cell Lung Cancers to Cisplatin and Doxorubicin
- (2013) D. H. Shin et al. CANCER RESEARCH
- miR-9 Regulation of BRCA1 and Ovarian Cancer Sensitivity to Cisplatin and PARP Inhibition
- (2013) Chaoyang Sun et al. JNCI-Journal of the National Cancer Institute
- BRCA1-Dependent Translational Regulation in Breast Cancer Cells
- (2013) Estelle Dacheux et al. PLoS One
- Molecular mechanisms of cisplatin resistance
- (2011) L Galluzzi et al. ONCOGENE
- ERCC1 and BRCA1 mRNA expression levels in metastatic malignant effusions is associated with chemosensitivity to cisplatin and/or docetaxel
- (2008) Lifeng Wang et al. BMC CANCER
- Regulation of apoptosis-inducing factor-mediated, cisplatin-induced apoptosis by Akt
- (2008) X Yang et al. BRITISH JOURNAL OF CANCER
- S-1 plus cisplatin versus S-1 alone for first-line treatment of advanced gastric cancer (SPIRITS trial): a phase III trial
- (2008) Wasaburo Koizumi et al. LANCET ONCOLOGY
- Doxorubicin activates FOXO3a to induce the expression of multidrug resistance gene ABCB1 (MDR1) in K562 leukemic cells
- (2008) R. C-Y. Hui et al. MOLECULAR CANCER THERAPEUTICS
- -H2AX in recognition and signaling of DNA double-strand breaks in the context of chromatin
- (2008) A. Kinner et al. NUCLEIC ACIDS RESEARCH
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now